Primary Peritoneal Carcinoma Recruiting Phase 1 Trials for Fludeoxyglucose F-18 (DB09502)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03604315Fluorine F 18 Fluorthanatrace PET/CT in Treating Participants With Primary or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment